---
title: The BALB/c.mdx62 mouse exhibits a dystrophic muscle pathology and is a novel
  model of Duchenne muscular dystrophy
date: '2024-04-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38602028/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240411180910&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Duchenne muscular dystrophy (DMD) is a devastating monogenic skeletal
  muscle wasting disorder. While many pharmacological and genetic interventions have
  been reported in preclinical studies, few have progressed to clinical trials with
  meaningful benefit. Identifying therapeutic potential may be limited by availability
  of suitable preclinical mouse models. More rigorous testing across models with varied
  background strains and mutations may identify treatments for clinical success. Here
  we ...
disable_comments: true
---
Duchenne muscular dystrophy (DMD) is a devastating monogenic skeletal muscle wasting disorder. While many pharmacological and genetic interventions have been reported in preclinical studies, few have progressed to clinical trials with meaningful benefit. Identifying therapeutic potential may be limited by availability of suitable preclinical mouse models. More rigorous testing across models with varied background strains and mutations may identify treatments for clinical success. Here we ...